바이오로직스 자료
Advancing biologics development with next-generation cell line development
As biologics grow more complex, cell line development (CLD) must advance with them. This whitepaper explores how Samsung Biologics’ next-generation CLD platforms—S-CHOice® and S-AfuCHO™—are designed to deliver speed, consistency, and enhanced control over product quality.
Learn how innovations like transposase-mediated integration and high-throughput lectin assays are helping streamline early development and support clinical success.
As biologics grow more complex, cell line development (CLD) must advance with them. This whitepaper explores how Samsung Biologics’ next-generation CLD platforms—S-CHOice® and S-AfuCHO™—are designed to deliver speed, consistency, and enhanced control over product quality.
Learn how innovations like transposase-mediated integration and high-throughput lectin assays are helping streamline early development and support clinical success.